Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Omenn Syndrome
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
8
Start Date:
August 2021
Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Clinical Trial
Status:
Recruiting
Intervention Type:
Drug
Participants:
50
Start Date:
August 20, 2020
A Prospective Outcomes Study of Pediatric and Adult Patients With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation With a Reduced-Intensity Conditioning Regimen (PRO-RIC)
Search for trials
Clinical Trial
Status:
Recruiting
Intervention Type:
Biological
Participants:
20
Start Date:
June 25, 2019
Single Arm, Open-Label, Multicenter, Registry Study of Revcovi (Elapegademase-lvlr) Treatment in ADA-SCID Patients Requiring Enzyme Replacement Therapy
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
5
Start Date:
December 21, 2018
Phase I/II Study of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Genetic
Participants:
10
Start Date:
October 30, 2018
Gene Transfer for Adenosine Deaminase-severe Combined Immunodeficiency (ADA-SCID) Using an Improved Self-inactivating Lentiviral Vector (TYF-ADA)
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Biological
Participants:
10
Start Date:
January 19, 2018
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug, Genetic
Participants:
10
Start Date:
January 3, 2018
Efficacy and Safety of a Cryopreserved Formulation of Autologous CD34+ Haematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1α Short Form (EFS) Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency (SCID) Due to Adenosine Deaminase Deficiency
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
42
Start Date:
March 20, 2017
A Phase I Study To Evaluate The Safety And Tolerability of JSP191 For Hematopoietic Cell Transplantation Conditioning To Achieve Engraftment And Immune Reconstitution In Subjects With SCID
Clinical Trial
Status:
Recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Device, Genetic, Drug
Participants:
28
Start Date:
August 17, 2016
A Pilot Feasibility Study of Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Using a Self-Inactivating Lentiviral Vector to Transduce Autologous CD34+ Hematopoietic Cells
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
100
Start Date:
February 4, 2014
A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults ≤55 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
20
Start Date:
March 2013
A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Immune Function Disorders Using a Reduced Intensity Preparatory Regime
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Drug, Biological
Participants:
30
Start Date:
September 4, 2012
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
Showing 1-12 of 15
Next